{"gene":"MLF2","run_date":"2026-04-28T18:30:28","timeline":{"discoveries":[{"year":1996,"finding":"MLF2 was identified as a novel gene encoding a 248-amino-acid protein with 63% similarity and 40% identity to MLF1. Unlike the tissue-restricted MLF1, MLF2 mRNA is expressed ubiquitously. The MLF2 gene was mapped by fluorescence in situ hybridization to human chromosome 12p13, a region frequently rearranged in acute leukemias, though Southern blotting of leukemia cell DNAs failed to reveal MLF2 gene rearrangements.","method":"cDNA cloning, Northern blotting, FISH chromosomal mapping, Southern blotting","journal":"Genomics","confidence":"High","confidence_rationale":"Tier 1-2 foundational cloning paper with multiple orthogonal methods; original characterization of the gene","pmids":["8661158"],"is_preprint":false},{"year":2006,"finding":"MLF2 was detected as a phosphoprotein in the human mitotic spindle, with phosphorylation sites identified by mass spectrometry, indicating MLF2 is present and phosphorylated during mitosis.","method":"Mass spectrometry-based phosphoproteomics of purified human mitotic spindles","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Low","confidence_rationale":"Tier 3 — single MS detection in a large-scale screen, no functional follow-up on MLF2 specifically","pmids":["16565220"],"is_preprint":false},{"year":2007,"finding":"MLF2 was localized to specific subcellular compartment(s) in human cell lines by antibody-based confocal microscopy in a large-scale subcellular atlas study.","method":"Immunofluorescence confocal microscopy with protein-specific antibodies","journal":"Molecular & cellular proteomics : MCP","confidence":"Low","confidence_rationale":"Tier 3 — large-scale atlas, localization of MLF2 reported but no functional consequence linked","pmids":["18029348"],"is_preprint":false},{"year":2012,"finding":"MLF2 was identified as an mRNA-binding protein (RBP) in human HeLa cells by systematic UV crosslinking of RBPs to RNA (interactome capture), placing MLF2 among >860 proteins that directly contact mRNA.","method":"UV crosslinking followed by oligo(dT) capture and mass spectrometry (interactome capture)","journal":"Cell","confidence":"Medium","confidence_rationale":"Tier 2 — biochemical covalent crosslinking with stringent criteria in a highly cited study; single lab but rigorous method","pmids":["22658674"],"is_preprint":false},{"year":2014,"finding":"Selective shRNA knockdown of MLF2 in breast cancer cell lines and patient-derived xenografts reduced tumor volume, lung metastases, and breast cancer stem cell (BCSC) self-renewal. RNA deep sequencing identified damaging mutations in MLF2 associated with pulmonary metastasis. Both MLF2 and RPL39 were found to affect the nitric oxide synthase (NOS) pathway and are regulated by hypoxia.","method":"shRNA knockdown, siRNA nanoparticle delivery in xenografts, RNA deep sequencing, patient biopsy analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function with defined cellular phenotype (BCSC self-renewal, tumor volume, metastasis) and pathway placement (NOS), single lab with multiple readouts","pmids":["24876273"],"is_preprint":false},{"year":2015,"finding":"MLF2 was identified as a CRM1-dependent nuclear export substrate in human cells, indicating that MLF2 undergoes CRM1-mediated nucleocytoplasmic shuttling.","method":"Quantitative mass spectrometry-based CRM1 cargo identification combined with nuclear/cytoplasmic partitioning measurements in human cells","journal":"eLife","confidence":"Medium","confidence_rationale":"Tier 2 — quantitative MS with CRM1 inhibition (leptomycin B) in a deep proteomics study; single lab large-scale approach","pmids":["26673895"],"is_preprint":false},{"year":2019,"finding":"MLF2 plays an oncogenic role in CML and its activity requires phosphorylation at serine 24. Phosphorylation at S24 was detected by Phos-tag SDS-PAGE. Point mutation of S24 abolished the ability of MLF2 overexpression to enhance colony formation in vitro and promote leukemogenesis in vivo (mouse survival model). MLF2 expression levels correlated with proliferation, colony formation, and imatinib sensitivity in K562 cells.","method":"Phos-tag SDS-PAGE, site-directed mutagenesis (S24A), colony formation assay, mouse survival model, siRNA knockdown","journal":"Cancer gene therapy","confidence":"Medium","confidence_rationale":"Tier 2 — phosphorylation detected biochemically, functional consequence validated by mutagenesis in vitro and in vivo; single lab","pmids":["31831854"],"is_preprint":false},{"year":2020,"finding":"MLF2 was identified by proteomics as a luminal component of nuclear envelope (NE) blebs formed upon Torsin ATPase manipulation. Using an MLF2-based live-cell imaging platform, NE blebbing was shown to occur rapidly and synchronously immediately after nuclear envelope reformation during mitosis. Bleb formation was independent of ubiquitin conjugation within the bleb but strictly dependent on POM121 (a transmembrane nucleoporin essential for interphase NPC biogenesis). Nup358, a late marker for NPC biogenesis, was underrepresented in Torsin-deficient cells, leading to the conclusion that NE blebs represent aberrant NPC intermediates.","method":"Proteomics (mass spectrometry), live-cell fluorescence imaging with MLF2 as reporter, genetic epistasis (POM121 dependence), immunofluorescence, fractionation","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (proteomics, live imaging, genetic epistasis with POM121), mechanistic link established between Torsin ATPase, NPC biogenesis, and MLF2-marked blebs","pmids":["32342107"],"is_preprint":false},{"year":2023,"finding":"MLF2 functions as a negative regulator of p53 by interacting with both p53 and USP7 (a deubiquitinase for p53 and MDM2). Via these interactions, MLF2 inhibits USP7 binding to p53 and antagonizes USP7-mediated deubiquitination of p53, thereby promoting p53 destabilization (increased ubiquitination and degradation). MLF2 plays an oncogenic role in colorectal cancer at least partially through this p53-suppression mechanism.","method":"Co-immunoprecipitation, ubiquitination assays, MLF2 knockdown/overexpression with p53 stability readouts, colorectal cancer cell line experiments","journal":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP establishing ternary complex (MLF2/p53/USP7), ubiquitination assay demonstrating mechanistic consequence, loss-of-function with defined molecular phenotype; single lab but multiple orthogonal methods","pmids":["37438558"],"is_preprint":false},{"year":2024,"finding":"MLF2 was identified as a chaperone-like protein that regulates a subset of SWI/SNF (BAF) complex target genes by promoting chromatin remodeling activity. In a genome-wide CRISPR KO screen in mouse embryonic stem cells, MLF2 loss impaired SWI/SNF-dependent chromatin remodeling at specific loci, establishing MLF2 as a regulator of SWI/SNF complex activity.","method":"Genome-wide CRISPR KO screen with epigenome editing readout, chromatin accessibility assays, gene expression analysis in mouse embryonic stem cells","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — CRISPR KO with chromatin remodeling functional readout; preprint, single lab, awaiting peer review","pmids":["bio_10.1101_2024.06.25.600572"],"is_preprint":true},{"year":2025,"finding":"MLF2 was established as a disease-agnostic biomarker and reporter of biomolecular phase transitions (condensate formation). Using MLF2 as a high-content screening readout in an imaging platform, a genome-wide CRISPR/Cas9 screen identified genes linked to primary microcephaly (including ZNF335 and RNF26) that cause proteotoxic condensates. RNF26 deletion provoked nuclear envelope condensates reminiscent of NPC defects, while ZNF335 loss drove nucleoplasmic condensates, establishing a link between aberrant phase transitions and neurodevelopmental disorders.","method":"High-content fluorescence imaging using MLF2 as condensate reporter, genome-wide CRISPR/Cas9 screen, machine learning phenotypic clustering, FDA-approved drug screening","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — genome-wide CRISPR screen with MLF2-based imaging readout and machine learning validation; preprint, novel mechanistic findings not yet peer-reviewed","pmids":["bio_10.1101_2025.06.07.658469"],"is_preprint":true}],"current_model":"MLF2 is a ubiquitously expressed protein that localizes to the nuclear envelope lumen (marking aberrant NPC intermediates in Torsin-deficient cells), undergoes CRM1-mediated nuclear export, acts as an mRNA-binding protein, suppresses p53 by interacting with both p53 and USP7 to antagonize USP7-mediated p53 deubiquitination, requires phosphorylation at serine 24 for its oncogenic activity in CML, functions as a chaperone-like regulator of SWI/SNF chromatin remodeling, and serves as a reporter of biomolecular condensate/phase transition states linked to nuclear pore biogenesis."},"narrative":{"teleology":[{"year":1996,"claim":"Identification of MLF2 as a novel gene with ubiquitous expression and chromosomal mapping to 12p13 established it as a paralog of MLF1, though no leukemia-associated rearrangements were found at the MLF2 locus.","evidence":"cDNA cloning, Northern blotting, FISH mapping, and Southern blotting of leukemia cell lines","pmids":["8661158"],"confidence":"High","gaps":["No functional role assigned","Protein localization undetermined","Relationship to leukemogenesis unclear despite chromosomal location"]},{"year":2012,"claim":"Discovery that MLF2 directly contacts mRNA via UV crosslinking established an unexpected RNA-binding capacity for a protein with no canonical RNA-binding domain.","evidence":"UV crosslinking followed by oligo(dT) capture and mass spectrometry in HeLa cells","pmids":["22658674"],"confidence":"Medium","gaps":["Specific RNA targets unknown","Functional consequence of mRNA binding not determined","RNA-binding domain or motif not mapped"]},{"year":2015,"claim":"Identification of MLF2 as a CRM1-dependent nuclear export substrate revealed that the protein undergoes active nucleocytoplasmic shuttling, providing a mechanistic basis for its presence in both nuclear and cytoplasmic compartments.","evidence":"Quantitative mass spectrometry with CRM1 inhibition (leptomycin B) in human cells","pmids":["26673895"],"confidence":"Medium","gaps":["Nuclear export signal not mapped within MLF2","Functional significance of shuttling not established","Whether shuttling regulates MLF2 activity unknown"]},{"year":2019,"claim":"Demonstrating that phosphorylation at serine 24 is required for MLF2's oncogenic activity in CML resolved how a post-translational modification controls MLF2 function in leukemogenesis.","evidence":"Phos-tag SDS-PAGE, S24A mutagenesis abolishing colony formation in vitro and leukemogenesis in a mouse survival model","pmids":["31831854"],"confidence":"Medium","gaps":["Kinase responsible for S24 phosphorylation not identified","Downstream effectors of phospho-MLF2 in CML unknown","Whether S24 phosphorylation affects p53-related or NPC-related functions not tested"]},{"year":2020,"claim":"Establishing MLF2 as a luminal component of nuclear envelope blebs in Torsin-deficient cells, dependent on POM121 and representing stalled NPC intermediates, provided the first mechanistic link between MLF2, nuclear pore biogenesis, and the nuclear envelope.","evidence":"Proteomics, live-cell imaging with MLF2 reporter, genetic epistasis showing POM121 dependence and Nup358 underrepresentation","pmids":["32342107"],"confidence":"High","gaps":["How MLF2 is recruited to the NE lumen is unknown","Whether MLF2 is functionally required for NPC biogenesis or is a passive marker not resolved","Relationship between NE bleb phenotype and Torsin-linked dystonia pathology not established"]},{"year":2023,"claim":"Discovery that MLF2 interacts with both p53 and USP7 to antagonize USP7-mediated p53 deubiquitination defined a molecular mechanism for MLF2's oncogenic activity, explaining how MLF2 promotes p53 destabilization in colorectal cancer.","evidence":"Reciprocal co-immunoprecipitation of MLF2/p53/USP7, ubiquitination assays, knockdown and overexpression with p53 stability readouts in colorectal cancer cells","pmids":["37438558"],"confidence":"High","gaps":["Whether MLF2-USP7 interaction also affects MDM2 stability not fully dissected","Structural basis of the ternary complex unknown","Whether the p53-suppression mechanism operates in CML or other MLF2-linked cancers not tested"]},{"year":null,"claim":"Key unresolved questions include whether MLF2 plays an active functional role in NPC biogenesis versus serving as a passive marker, the identity of the kinase phosphorylating S24, the specific mRNA targets bound by MLF2, and whether its disparate roles in chromatin remodeling, p53 regulation, and nuclear envelope biology are mechanistically linked or context-dependent.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural model of MLF2 exists","Integration of RNA-binding, p53 regulation, NPC biology, and SWI/SNF functions into a unified model is lacking","In vivo genetic models (knockout mouse) have not been reported"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[3]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[8,9]}],"localization":[{"term_id":"GO:0005635","term_label":"nuclear envelope","supporting_discovery_ids":[7,10]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[5,7]}],"pathway":[{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[7,10]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[4,6,8]}],"complexes":[],"partners":["USP7","TP53","POM121"],"other_free_text":[]},"mechanistic_narrative":"MLF2 is a ubiquitously expressed protein that functions at the intersection of nuclear envelope biology, chromatin regulation, and p53-mediated tumor suppression. MLF2 localizes to the nuclear envelope lumen where it marks aberrant nuclear pore complex (NPC) intermediates in Torsin ATPase-deficient cells, with bleb formation dependent on the transmembrane nucleoporin POM121 and occurring immediately after post-mitotic nuclear envelope reformation [PMID:32342107]. MLF2 suppresses p53 stability by binding both p53 and the deubiquitinase USP7, thereby antagonizing USP7-mediated p53 deubiquitination and promoting p53 degradation, a mechanism that contributes to its oncogenic role in colorectal cancer [PMID:37438558]. MLF2 undergoes CRM1-dependent nucleocytoplasmic shuttling [PMID:26673895], binds mRNA [PMID:22658674], and requires phosphorylation at serine 24 for its oncogenic activity in chronic myeloid leukemia [PMID:31831854]."},"prefetch_data":{"uniprot":{"accession":"Q15773","full_name":"Myeloid leukemia factor 2","aliases":["Myelodysplasia-myeloid leukemia factor 2"],"length_aa":248,"mass_kda":28.1,"function":"","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q15773/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MLF2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/MLF2","total_profiled":1310},"omim":[{"mim_id":"601402","title":"MYELOID LEUKEMIA FACTOR 1; MLF1","url":"https://www.omim.org/entry/601402"},{"mim_id":"601401","title":"MYELOID LEUKEMIA FACTOR 2; MLF2","url":"https://www.omim.org/entry/601401"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Plasma membrane","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/MLF2"},"hgnc":{"alias_symbol":["NTN4"],"prev_symbol":[]},"alphafold":{"accession":"Q15773","domains":[{"cath_id":"-","chopping":"99-203","consensus_level":"medium","plddt":88.6663,"start":99,"end":203}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q15773","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q15773-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q15773-F1-predicted_aligned_error_v6.png","plddt_mean":65.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MLF2","jax_strain_url":"https://www.jax.org/strain/search?query=MLF2"},"sequence":{"accession":"Q15773","fasta_url":"https://rest.uniprot.org/uniprotkb/Q15773.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q15773/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q15773"}},"corpus_meta":[{"pmid":"24876273","id":"PMC_24876273","title":"Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24876273","citation_count":94,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32342107","id":"PMC_32342107","title":"Torsin ATPase deficiency leads to defects in nuclear pore biogenesis and sequestration of MLF2.","date":"2020","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/32342107","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27840993","id":"PMC_27840993","title":"NTN4 is associated with breast cancer metastasis via regulation of EMT-related biomarkers.","date":"2016","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/27840993","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25042818","id":"PMC_25042818","title":"Genetic association signal near NTN4 in Tourette syndrome.","date":"2014","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/25042818","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24972566","id":"PMC_24972566","title":"miR-20a contributes to endometriosis by regulating NTN4 expression.","date":"2014","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/24972566","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32871102","id":"PMC_32871102","title":"eQTL Colocalization Analyses Identify NTN4 as a Candidate Breast Cancer Risk Gene.","date":"2020","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32871102","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8661158","id":"PMC_8661158","title":"cDNA cloning, tissue distribution, and chromosomal localization of myelodysplasia/myeloid leukemia factor 2 (MLF2).","date":"1996","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8661158","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30928649","id":"PMC_30928649","title":"3'UTR variants of TNS3, PHLDB1, NTN4, and GNG2 genes are associated with IgA nephropathy risk in Chinese Han population.","date":"2019","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30928649","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37438558","id":"PMC_37438558","title":"MLF2 Negatively Regulates P53 and Promotes Colorectal Carcinogenesis.","date":"2023","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/37438558","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38164180","id":"PMC_38164180","title":"EXOSC5 maintains cancer stem cell activity in endometrial cancer by regulating the NTN4/integrin β1 signalling axis.","date":"2024","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38164180","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31831854","id":"PMC_31831854","title":"The role of phosphorylation of MLF2 at serine 24 in BCR-ABL leukemogenesis.","date":"2019","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/31831854","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38175202","id":"PMC_38175202","title":"CD204-positive M2-like tumor-associated macrophages increase migration of gastric cancer cells by upregulating miR-210 to reduce NTN4 expression.","date":"2024","source":"Cancer immunology, immunotherapy : CII","url":"https://pubmed.ncbi.nlm.nih.gov/38175202","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35687692","id":"PMC_35687692","title":"The risk variant rs11836367 contributes to breast cancer onset and metastasis by attenuating Wnt signaling via regulating NTN4 expression.","date":"2022","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/35687692","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27920664","id":"PMC_27920664","title":"Investigation of SNP rs2060546 Immediately Upstream to NTN4 in a Danish Gilles de la Tourette Syndrome Cohort.","date":"2016","source":"Frontiers in neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/27920664","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35232666","id":"PMC_35232666","title":"The Interaction of NTN4 and miR-17-92 Polymorphisms on Breast Cancer Susceptibility in a Chinese Population.","date":"2021","source":"Clinical breast cancer","url":"https://pubmed.ncbi.nlm.nih.gov/35232666","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40136644","id":"PMC_40136644","title":"Association Between Synovial NTN4 Expression and Pain Scores, and Its Effects on Fibroblasts and Sensory Neurons in End-Stage Knee Osteoarthritis.","date":"2025","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/40136644","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38156865","id":"PMC_38156865","title":"Hepatic Expression of NTN4 and Its Receptors in Patients with Hepatocellular Carcinoma.","date":"2023","source":"Asian Pacific journal of cancer prevention : APJCP","url":"https://pubmed.ncbi.nlm.nih.gov/38156865","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21645301","id":"PMC_21645301","title":"Identification of parental line specific effects of MLF2 on resistance to coccidiosis in chickens.","date":"2011","source":"BMC proceedings","url":"https://pubmed.ncbi.nlm.nih.gov/21645301","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40688916","id":"PMC_40688916","title":"Elevation of NTN4 Expression and Its Possible Regulation by Tumor Necrosis Factor-Alpha (TNF-α) in a Rat Model of Rotator Cuff Tear.","date":"2025","source":"Cureus","url":"https://pubmed.ncbi.nlm.nih.gov/40688916","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.06.07.658469","title":"Integrative Chemical Genetics Platform Identifies Condensate Modulators Linked to Neurological Disorders","date":"2025-06-08","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.07.658469","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2024.06.25.600572","title":"CRISPR screen decodes SWI/SNF chromatin remodeling complex assembly","date":"2024-06-25","source":"bioRxiv","url":"https://doi.org/10.1101/2024.06.25.600572","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.01.30.25321017","title":"Genome-wide association study of Idiopathic Pulmonary Fibrosis susceptibility using clinically-curated European-ancestry datasets","date":"2025-02-02","source":"bioRxiv","url":"https://doi.org/10.1101/2025.01.30.25321017","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2024.09.18.24313937","title":"Rare Variant Association Analysis Uncovers Involvement of<i>VNN2</i>in Stroke Outcome","date":"2024-09-19","source":"bioRxiv","url":"https://doi.org/10.1101/2024.09.18.24313937","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2024.07.08.24310079","title":"Overlap between COPD genetic association results and transcriptional quantitative trait loci","date":"2024-07-08","source":"bioRxiv","url":"https://doi.org/10.1101/2024.07.08.24310079","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":"22658674","id":"PMC_22658674","title":"Insights into RNA biology from an atlas of mammalian mRNA-binding proteins.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22658674","citation_count":1718,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20562859","id":"PMC_20562859","title":"Network organization of the human autophagy system.","date":"2010","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/20562859","citation_count":1286,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19490893","id":"PMC_19490893","title":"A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene.","date":"2009","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/19490893","citation_count":843,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29507755","id":"PMC_29507755","title":"VIRMA mediates preferential m6A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation.","date":"2018","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/29507755","citation_count":829,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17353931","id":"PMC_17353931","title":"Large-scale mapping of human protein-protein interactions by mass spectrometry.","date":"2007","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/17353931","citation_count":733,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33845483","id":"PMC_33845483","title":"Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/33845483","citation_count":532,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25036637","id":"PMC_25036637","title":"A quantitative chaperone interaction network reveals the architecture of cellular protein homeostasis pathways.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25036637","citation_count":325,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16565220","id":"PMC_16565220","title":"Phosphoproteome analysis of the human mitotic spindle.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16565220","citation_count":281,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22863883","id":"PMC_22863883","title":"A high-throughput approach for measuring temporal changes in the interactome.","date":"2012","source":"Nature methods","url":"https://pubmed.ncbi.nlm.nih.gov/22863883","citation_count":273,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21654808","id":"PMC_21654808","title":"A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers.","date":"2011","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/21654808","citation_count":269,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21139048","id":"PMC_21139048","title":"Mass spectrometric analysis of lysine ubiquitylation reveals promiscuity at site level.","date":"2010","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/21139048","citation_count":262,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23752268","id":"PMC_23752268","title":"The functional interactome landscape of the human histone deacetylase family.","date":"2013","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/23752268","citation_count":235,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22678362","id":"PMC_22678362","title":"MMS19 assembles iron-sulfur proteins required for DNA metabolism and genomic integrity.","date":"2012","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/22678362","citation_count":230,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27705803","id":"PMC_27705803","title":"A High-Density Map for Navigating the Human Polycomb Complexome.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27705803","citation_count":216,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29568061","id":"PMC_29568061","title":"An AP-MS- and BioID-compatible MAC-tag enables comprehensive mapping of protein interactions and subcellular localizations.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29568061","citation_count":201,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26673895","id":"PMC_26673895","title":"A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.","date":"2015","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/26673895","citation_count":198,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32203420","id":"PMC_32203420","title":"Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.","date":"2020","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/32203420","citation_count":194,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16196087","id":"PMC_16196087","title":"Large-scale analysis of the human ubiquitin-related proteome.","date":"2005","source":"Proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/16196087","citation_count":154,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32877691","id":"PMC_32877691","title":"A High-Density Human Mitochondrial Proximity Interaction Network.","date":"2020","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/32877691","citation_count":148,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23891004","id":"PMC_23891004","title":"Human CIA2A-FAM96A and CIA2B-FAM96B integrate iron homeostasis and maturation of different subsets of cytosolic-nuclear iron-sulfur proteins.","date":"2013","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/23891004","citation_count":142,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31871319","id":"PMC_31871319","title":"Mapping the proximity interaction network of the Rho-family GTPases reveals signalling pathways and regulatory mechanisms.","date":"2019","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/31871319","citation_count":137,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29117863","id":"PMC_29117863","title":"RNA-binding activity of TRIM25 is mediated by its PRY/SPRY domain and is required for ubiquitination.","date":"2017","source":"BMC biology","url":"https://pubmed.ncbi.nlm.nih.gov/29117863","citation_count":135,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35013556","id":"PMC_35013556","title":"The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin.","date":"2022","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/35013556","citation_count":122,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27545878","id":"PMC_27545878","title":"SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27545878","citation_count":115,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18029348","id":"PMC_18029348","title":"Toward a confocal subcellular atlas of the human proteome.","date":"2007","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/18029348","citation_count":114,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":13751,"output_tokens":1785,"usd":0.034014},"stage2":{"model":"claude-opus-4-6","input_tokens":5025,"output_tokens":1841,"usd":0.106725},"total_usd":0.332943,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":25461,"output_tokens":4861,"usd":0.074649},"round2_rules_fired":"R2,R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":6454,"output_tokens":1844,"usd":0.117555}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"MLF2 encodes a 248-amino-acid protein with 63% similarity and 40% identity to MLF1; its mRNA is expressed ubiquitously (in contrast to tissue-restricted MLF1), and the MLF2 gene maps to human chromosome 12p13.\",\n      \"method\": \"cDNA cloning, Northern blotting, fluorescence in situ hybridization, Southern blotting\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct molecular characterization with multiple orthogonal methods in a single study\",\n      \"pmids\": [\"8661158\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"MLF2 is a luminal component of nuclear envelope (NE) blebs that form in Torsin ATPase-deficient cells; live-cell imaging with MLF2 as a reporter showed that NE blebbing occurs rapidly and synchronously immediately after NE reformation during mitosis, is dependent on the transmembrane nucleoporin POM121, and represents aberrant nuclear pore complex (NPC) intermediates formed during interphase NPC biogenesis.\",\n      \"method\": \"Proteomics (mass spectrometry of bleb contents), MLF2-based live-cell imaging platform, genetic dependence assays (POM121 depletion), Nup358 immunofluorescence quantification\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (proteomics, live imaging, genetic epistasis) in a single study with rigorous controls\",\n      \"pmids\": [\"32342107\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Knockdown of MLF2 reduces breast cancer stem cell (BCSC) self-renewal, tumor volume, and lung metastases in patient-derived and human cancer xenografts; both MLF2 and RPL39 affect the nitric oxide synthase (NOS) pathway and are regulated by hypoxia.\",\n      \"method\": \"shRNA/siRNA nanoparticle knockdown in xenograft models, RNA deep sequencing, BCSC self-renewal assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo loss-of-function with defined cellular phenotype, but pathway placement (NOS) is based on transcriptomics rather than direct biochemical assay\",\n      \"pmids\": [\"24876273\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MLF2 is phosphorylated at serine 24, and this phosphorylation is required for its oncogenic activity in CML; point mutation of serine 24 abolishes the ability of MLF2 overexpression to enhance colony formation in vitro and reduces its effect on mouse survival in vivo.\",\n      \"method\": \"Phos-tag SDS-PAGE to detect phosphorylation, site-directed mutagenesis (S24A), colony-formation assay, mouse survival in vivo\",\n      \"journal\": \"Cancer gene therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis combined with functional assays in vitro and in vivo, but writer kinase not identified\",\n      \"pmids\": [\"31831854\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"MLF2 interacts with both p53 and USP7 (a deubiquitinase for p53); MLF2 inhibits USP7 binding to p53 and antagonizes USP7-mediated deubiquitination of p53, thereby promoting p53 ubiquitination and destabilization, playing an oncogenic role in colorectal cancer.\",\n      \"method\": \"Co-immunoprecipitation, deubiquitination assays, MLF2 knockdown/overexpression with p53 stability measurements, in vivo tumor models\",\n      \"journal\": \"Advanced science (Weinheim, Baden-Wurttemberg, Germany)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct binding demonstrated by Co-IP, enzymatic mechanism (deubiquitination antagonism) shown in vitro, validated with functional in vivo readout\",\n      \"pmids\": [\"37438558\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"MLF2 undergoes phase transitions and can be used as a disease-agnostic biomarker of biomolecular condensate formation; in a genome-wide CRISPR/Cas9 screen using MLF2 condensate state as a readout, MLF2 localization to nuclear envelope condensates was linked to nuclear pore defects (phenocopied by RNF26 deletion), establishing MLF2 as a reporter for aberrant phase transitions.\",\n      \"method\": \"Genome-wide CRISPR/Cas9 screen, high-content imaging of MLF2 condensates, machine learning phenotypic clustering\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — CRISPR screen with MLF2 as functional readout, but preprint and mechanistic details of MLF2 condensate biology are not fully resolved\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"MLF2 regulates a subset of SWI/SNF target genes by promoting chromatin remodeling activity; identified as a regulator of SWI/SNF complex activity in a genome-wide CRISPR KO screen using epigenome editing in mouse embryonic stem cells, and described as a chaperone protein for SWI/SNF.\",\n      \"method\": \"Genome-wide CRISPR KO screen, epigenome editing, gene expression analysis of SWI/SNF target genes\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — preprint, single screen-based method, limited mechanistic follow-up on MLF2-SWI/SNF interaction\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"MLF2 is a ubiquitously expressed protein that localizes to the nuclear envelope lumen and functions as a component of aberrant NPC intermediates in Torsin ATPase-deficient cells; it negatively regulates p53 stability by binding both p53 and the deubiquitinase USP7 to antagonize USP7-mediated p53 deubiquitination; its oncogenic activity in CML requires phosphorylation at serine 24; and it undergoes phase transitions that can serve as a readout for biomolecular condensate dysregulation linked to nuclear pore biogenesis defects.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll classify each paper first, then extract discoveries only from KEPT papers.\n\n**Classification:**\n\n- PMID:24876273 — KEEP (MLF2 knockdown in breast cancer, nitric oxide synthase pathway)\n- PMID:32342107 — KEEP (MLF2 as luminal component of nuclear envelope blebs, Torsin ATPase, NPC biogenesis)\n- PMID:27840993 — EXCLUDE (NTN4 paper, alias collision)\n- PMID:25042818 — EXCLUDE (NTN4/Tourette syndrome GWAS)\n- PMID:24972566 — EXCLUDE (NTN4 miR-20a endometriosis)\n- PMID:32871102 — EXCLUDE (NTN4 breast cancer eQTL)\n- PMID:8661158 — KEEP (MLF2 cDNA cloning, chromosomal localization, tissue expression)\n- PMID:30928649 — EXCLUDE (NTN4 IgA nephropathy)\n- PMID:37438558 — KEEP (MLF2 negatively regulates p53 via USP7 interaction)\n- PMID:38164180 — EXCLUDE (NTN4/EXOSC5 endometrial cancer)\n- PMID:31831854 — KEEP (MLF2 phosphorylation at serine 24 in CML/BCR-ABL)\n- PMID:38156865 — EXCLUDE (NTN4 hepatocellular carcinoma)\n- PMID:27920664 — EXCLUDE (NTN4 Tourette syndrome)\n- PMID:35687692 — EXCLUDE (NTN4 breast cancer GWAS)\n- PMID:35232666 — EXCLUDE (NTN4 breast cancer SNPs)\n- PMID:40136644 — EXCLUDE (NTN4 osteoarthritis)\n- PMID:38175202 — EXCLUDE (NTN4 gastric cancer miR-210)\n- PMID:21645301 — EXCLUDE (chicken MLF2, symbol collision — poultry coccidiosis resistance, fundamentally different context; the corpus is about human MLF2 with established roles in nuclear envelope biology and p53 regulation; this chicken genetics paper describes a QTL association study with no mechanistic overlap)\n- bio_10.1101_2025.06.07.658469 — KEEP (MLF2 as biomarker of phase transitions, condensate modulator)\n- bio_10.1101_2024.06.25.600572 — KEEP (MLF2 as chaperone-like regulator of SWI/SNF complex activity)\n- bio_10.1101_2025.01.30.25321017 — EXCLUDE (NTN4 IPF GWAS)\n- bio_10.1101_2024.09.18.24313937 — EXCLUDE (NTN4 stroke recovery)\n- bio_10.1101_2024.07.08.24310079 — EXCLUDE (NTN4 COPD sQTL)\n- PMID:40688916 — EXCLUDE (NTN4 rotator cuff)\n\n**gene2pubmed curated papers** — most are large proteomics/interactome screens; MLF2 appears as a hit in several. I will check each for MLF2-specific mechanistic findings:\n- PMID:22658674 — MLF2 identified as mRNA-binding protein (RBP) by UV crosslinking. KEEP (mechanistic: MLF2 has RNA-binding activity)\n- PMID:12477932 — MGC cDNA sequencing, no MLF2-specific mechanism. EXCLUDE\n- PMID:20562859 — Autophagy network; MLF2 not specifically highlighted. EXCLUDE\n- PMID:26496610 — Human interactome; MLF2 may appear but no specific mechanism. EXCLUDE\n- PMID:19490893 — RNAi screen for Ras synthetic lethality; no MLF2-specific mechanism described. EXCLUDE\n- PMID:29507755 — m6A methylation complex; no MLF2-specific mechanism. EXCLUDE\n- PMID:17353931 — Large-scale MS protein interactions; MLF2 may appear as interactor. EXCLUDE (no specific mechanistic finding)\n- PMID:33961781 — BioPlex 3.0 interactome; MLF2 as interactor but no specific mechanism described. EXCLUDE\n- PMID:21873635 — GO annotation propagation; no MLF2 mechanism. EXCLUDE\n- PMID:33845483 — SARS-CoV-2 proteomics; no MLF2-specific mechanism. EXCLUDE\n- PMID:15489334 — MGC cDNA; no MLF2 mechanism. EXCLUDE\n- PMID:25036637 — Chaperone network; MLF2 may appear. EXCLUDE\n- PMID:16565220 — Mitotic spindle phosphoproteome; MLF2 phosphorylation sites detected. KEEP (phosphorylation of MLF2 detected on mitotic spindle)\n- PMID:22863883 — Size-exclusion chromatography interactome; no MLF2 specific mechanism. EXCLUDE\n- PMID:21654808 — Cyclin D1 interactome; no MLF2 specific mechanism. EXCLUDE\n- PMID:21139048 — Ubiquitylation proteome; MLF2 may appear as ubiquitylated. EXCLUDE (no specific mechanism)\n- PMID:23752268 — HDAC interactome; no MLF2 mechanism. EXCLUDE\n- PMID:22678362 — MMS19/CIA machinery; no MLF2. EXCLUDE\n- PMID:27705803 — Polycomb complexome; no MLF2. EXCLUDE\n- PMID:29568061 — MAC-tag AP-MS/BioID; no MLF2 specific mechanism. EXCLUDE\n- PMID:26673895 — CRM1 nuclear export; MLF2 identified as CRM1 export substrate. KEEP\n- PMID:20203420 — RhoGEF/RhoGAP; no MLF2. EXCLUDE\n- PMID:31871319 — Rho GTPase proximity network; no MLF2. EXCLUDE\n- PMID:29117863 — TRIM25 RNA binding; no MLF2. EXCLUDE\n- PMID:35013556 — p97/PARP1; no MLF2. EXCLUDE\n- PMID:27545878 — SPATA2/CYLD/HOIP; no MLF2. EXCLUDE\n- PMID:18029348 — Subcellular atlas; MLF2 localization noted. KEEP (subcellular localization)\n- PMID:16196087 — Ubiquitin proteome; MLF2 as ubiquitylated protein. EXCLUDE (no specific mechanism beyond detection)\n- PMID:23891004 — CIA2A/CIA2B iron-sulfur; no MLF2. EXCLUDE\n- PMID:32203420 — RAC1 signaling; no MLF2. EXCLUDE\n- PMID:37871319 — Already checked. EXCLUDE\n\nNow for PMID:26673895 — the abstract states identification of >1050 CRM1 export substrates from human cells, with MLF2 identified among them. This is a Tier 2 finding (MS-based quantitative partitioning + CRM1 substrate identification).\n\nFor PMID:18029348 — subcellular localization atlas; MLF2 localization by confocal microscopy with antibodies. This is a direct localization experiment (Tier 3).\n\nFor PMID:16565220 — phosphoproteome of human mitotic spindle; MLF2 phosphorylation detected by MS. Tier 3 (single MS detection).\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"MLF2 was identified as a novel gene encoding a 248-amino-acid protein with 63% similarity and 40% identity to MLF1. Unlike the tissue-restricted MLF1, MLF2 mRNA is expressed ubiquitously. The MLF2 gene was mapped by fluorescence in situ hybridization to human chromosome 12p13, a region frequently rearranged in acute leukemias, though Southern blotting of leukemia cell DNAs failed to reveal MLF2 gene rearrangements.\",\n      \"method\": \"cDNA cloning, Northern blotting, FISH chromosomal mapping, Southern blotting\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 foundational cloning paper with multiple orthogonal methods; original characterization of the gene\",\n      \"pmids\": [\"8661158\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"MLF2 was detected as a phosphoprotein in the human mitotic spindle, with phosphorylation sites identified by mass spectrometry, indicating MLF2 is present and phosphorylated during mitosis.\",\n      \"method\": \"Mass spectrometry-based phosphoproteomics of purified human mitotic spindles\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single MS detection in a large-scale screen, no functional follow-up on MLF2 specifically\",\n      \"pmids\": [\"16565220\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"MLF2 was localized to specific subcellular compartment(s) in human cell lines by antibody-based confocal microscopy in a large-scale subcellular atlas study.\",\n      \"method\": \"Immunofluorescence confocal microscopy with protein-specific antibodies\",\n      \"journal\": \"Molecular & cellular proteomics : MCP\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — large-scale atlas, localization of MLF2 reported but no functional consequence linked\",\n      \"pmids\": [\"18029348\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"MLF2 was identified as an mRNA-binding protein (RBP) in human HeLa cells by systematic UV crosslinking of RBPs to RNA (interactome capture), placing MLF2 among >860 proteins that directly contact mRNA.\",\n      \"method\": \"UV crosslinking followed by oligo(dT) capture and mass spectrometry (interactome capture)\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — biochemical covalent crosslinking with stringent criteria in a highly cited study; single lab but rigorous method\",\n      \"pmids\": [\"22658674\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Selective shRNA knockdown of MLF2 in breast cancer cell lines and patient-derived xenografts reduced tumor volume, lung metastases, and breast cancer stem cell (BCSC) self-renewal. RNA deep sequencing identified damaging mutations in MLF2 associated with pulmonary metastasis. Both MLF2 and RPL39 were found to affect the nitric oxide synthase (NOS) pathway and are regulated by hypoxia.\",\n      \"method\": \"shRNA knockdown, siRNA nanoparticle delivery in xenografts, RNA deep sequencing, patient biopsy analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with defined cellular phenotype (BCSC self-renewal, tumor volume, metastasis) and pathway placement (NOS), single lab with multiple readouts\",\n      \"pmids\": [\"24876273\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"MLF2 was identified as a CRM1-dependent nuclear export substrate in human cells, indicating that MLF2 undergoes CRM1-mediated nucleocytoplasmic shuttling.\",\n      \"method\": \"Quantitative mass spectrometry-based CRM1 cargo identification combined with nuclear/cytoplasmic partitioning measurements in human cells\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — quantitative MS with CRM1 inhibition (leptomycin B) in a deep proteomics study; single lab large-scale approach\",\n      \"pmids\": [\"26673895\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MLF2 plays an oncogenic role in CML and its activity requires phosphorylation at serine 24. Phosphorylation at S24 was detected by Phos-tag SDS-PAGE. Point mutation of S24 abolished the ability of MLF2 overexpression to enhance colony formation in vitro and promote leukemogenesis in vivo (mouse survival model). MLF2 expression levels correlated with proliferation, colony formation, and imatinib sensitivity in K562 cells.\",\n      \"method\": \"Phos-tag SDS-PAGE, site-directed mutagenesis (S24A), colony formation assay, mouse survival model, siRNA knockdown\",\n      \"journal\": \"Cancer gene therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — phosphorylation detected biochemically, functional consequence validated by mutagenesis in vitro and in vivo; single lab\",\n      \"pmids\": [\"31831854\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"MLF2 was identified by proteomics as a luminal component of nuclear envelope (NE) blebs formed upon Torsin ATPase manipulation. Using an MLF2-based live-cell imaging platform, NE blebbing was shown to occur rapidly and synchronously immediately after nuclear envelope reformation during mitosis. Bleb formation was independent of ubiquitin conjugation within the bleb but strictly dependent on POM121 (a transmembrane nucleoporin essential for interphase NPC biogenesis). Nup358, a late marker for NPC biogenesis, was underrepresented in Torsin-deficient cells, leading to the conclusion that NE blebs represent aberrant NPC intermediates.\",\n      \"method\": \"Proteomics (mass spectrometry), live-cell fluorescence imaging with MLF2 as reporter, genetic epistasis (POM121 dependence), immunofluorescence, fractionation\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (proteomics, live imaging, genetic epistasis with POM121), mechanistic link established between Torsin ATPase, NPC biogenesis, and MLF2-marked blebs\",\n      \"pmids\": [\"32342107\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"MLF2 functions as a negative regulator of p53 by interacting with both p53 and USP7 (a deubiquitinase for p53 and MDM2). Via these interactions, MLF2 inhibits USP7 binding to p53 and antagonizes USP7-mediated deubiquitination of p53, thereby promoting p53 destabilization (increased ubiquitination and degradation). MLF2 plays an oncogenic role in colorectal cancer at least partially through this p53-suppression mechanism.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assays, MLF2 knockdown/overexpression with p53 stability readouts, colorectal cancer cell line experiments\",\n      \"journal\": \"Advanced science (Weinheim, Baden-Wurttemberg, Germany)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP establishing ternary complex (MLF2/p53/USP7), ubiquitination assay demonstrating mechanistic consequence, loss-of-function with defined molecular phenotype; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"37438558\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"MLF2 was identified as a chaperone-like protein that regulates a subset of SWI/SNF (BAF) complex target genes by promoting chromatin remodeling activity. In a genome-wide CRISPR KO screen in mouse embryonic stem cells, MLF2 loss impaired SWI/SNF-dependent chromatin remodeling at specific loci, establishing MLF2 as a regulator of SWI/SNF complex activity.\",\n      \"method\": \"Genome-wide CRISPR KO screen with epigenome editing readout, chromatin accessibility assays, gene expression analysis in mouse embryonic stem cells\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — CRISPR KO with chromatin remodeling functional readout; preprint, single lab, awaiting peer review\",\n      \"pmids\": [\"bio_10.1101_2024.06.25.600572\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"MLF2 was established as a disease-agnostic biomarker and reporter of biomolecular phase transitions (condensate formation). Using MLF2 as a high-content screening readout in an imaging platform, a genome-wide CRISPR/Cas9 screen identified genes linked to primary microcephaly (including ZNF335 and RNF26) that cause proteotoxic condensates. RNF26 deletion provoked nuclear envelope condensates reminiscent of NPC defects, while ZNF335 loss drove nucleoplasmic condensates, establishing a link between aberrant phase transitions and neurodevelopmental disorders.\",\n      \"method\": \"High-content fluorescence imaging using MLF2 as condensate reporter, genome-wide CRISPR/Cas9 screen, machine learning phenotypic clustering, FDA-approved drug screening\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide CRISPR screen with MLF2-based imaging readout and machine learning validation; preprint, novel mechanistic findings not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2025.06.07.658469\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"MLF2 is a ubiquitously expressed protein that localizes to the nuclear envelope lumen (marking aberrant NPC intermediates in Torsin-deficient cells), undergoes CRM1-mediated nuclear export, acts as an mRNA-binding protein, suppresses p53 by interacting with both p53 and USP7 to antagonize USP7-mediated p53 deubiquitination, requires phosphorylation at serine 24 for its oncogenic activity in CML, functions as a chaperone-like regulator of SWI/SNF chromatin remodeling, and serves as a reporter of biomolecular condensate/phase transition states linked to nuclear pore biogenesis.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"MLF2 is a ubiquitously expressed protein that functions at the intersection of nuclear envelope biology, p53 regulation, and chromatin organization. It localizes to the nuclear envelope lumen, where it accumulates in aberrant nuclear pore complex (NPC) intermediates that form in Torsin ATPase-deficient cells; live-cell imaging established that these NE blebs arise rapidly after mitotic NE reformation and depend on the transmembrane nucleoporin POM121 [PMID:32342107]. MLF2 negatively regulates p53 stability by binding both p53 and the deubiquitinase USP7, thereby antagonizing USP7-mediated p53 deubiquitination and promoting p53 degradation, which contributes to its oncogenic activity in colorectal cancer [PMID:37438558]. Phosphorylation of MLF2 at serine 24 is required for its oncogenic function in chronic myeloid leukemia, as mutation of this residue abolishes colony formation and reduces tumor-promoting activity in vivo [PMID:31831854].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Identification of MLF2 as a ubiquitously expressed paralogue of MLF1 established that the MLF gene family comprises two members with divergent tissue expression patterns, raising the question of MLF2's distinct function.\",\n      \"evidence\": \"cDNA cloning, Northern blotting, FISH mapping in human tissues\",\n      \"pmids\": [\"8661158\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No functional data; protein activity entirely unknown\",\n        \"Subcellular localization not determined\",\n        \"Relationship to MLF1 function unexplored\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Loss-of-function studies first linked MLF2 to an oncogenic phenotype, showing that MLF2 knockdown reduces breast cancer stem cell self-renewal and metastasis, implicating it in tumor biology.\",\n      \"evidence\": \"shRNA/siRNA knockdown in patient-derived xenograft models with BCSC self-renewal assays and RNA-seq\",\n      \"pmids\": [\"24876273\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"NOS pathway connection inferred from transcriptomics, not direct biochemistry\",\n        \"Mechanism by which MLF2 promotes stemness not defined\",\n        \"Whether effect is cell-autonomous not fully resolved\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Phosphorylation of MLF2 at serine 24 was shown to be essential for its oncogenic activity in CML, establishing a post-translational regulatory switch but leaving the responsible kinase unknown.\",\n      \"evidence\": \"Phos-tag SDS-PAGE, S24A site-directed mutagenesis, colony-formation assay, mouse survival studies\",\n      \"pmids\": [\"31831854\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Identity of the kinase phosphorylating S24 not determined\",\n        \"Downstream signaling pathway through which phospho-MLF2 acts not identified\",\n        \"Generalizability beyond CML not tested\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Proteomics and live-cell imaging revealed that MLF2 is a luminal component of nuclear envelope blebs in Torsin-deficient cells, establishing its subcellular localization and linking it to aberrant NPC biogenesis during interphase.\",\n      \"evidence\": \"Mass spectrometry of NE bleb contents, MLF2-based live-cell imaging, POM121 depletion epistasis, Nup358 quantification\",\n      \"pmids\": [\"32342107\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Direct molecular role of MLF2 in NPC assembly not defined\",\n        \"Whether MLF2 is passively trapped or actively recruited to blebs is unclear\",\n        \"Relationship between NE-lumen localization and cytoplasmic/nuclear functions unknown\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"The oncogenic mechanism of MLF2 was resolved at the biochemical level: MLF2 binds both p53 and USP7, competitively inhibiting USP7-mediated p53 deubiquitination and thereby promoting p53 degradation.\",\n      \"evidence\": \"Co-immunoprecipitation, in vitro deubiquitination assays, MLF2 knockdown/overexpression with p53 stability measurements, xenograft tumor models\",\n      \"pmids\": [\"37438558\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis of the MLF2–USP7 and MLF2–p53 interactions not resolved\",\n        \"Whether phosphorylation at S24 modulates p53/USP7 binding not tested\",\n        \"Whether this mechanism operates in all cancer types where MLF2 is oncogenic is unknown\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"A genome-wide CRISPR screen using MLF2 condensate state as a readout connected MLF2 phase transitions to nuclear pore defects, reinforcing its role as a sensor or reporter of NPC integrity.\",\n      \"evidence\": \"CRISPR/Cas9 screen with high-content imaging and machine learning phenotypic clustering (preprint)\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Preprint not yet peer-reviewed\",\n        \"Whether MLF2 condensates are functional or a passive consequence of NPC defects is unclear\",\n        \"Molecular determinants driving MLF2 phase separation not characterized\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the kinase that phosphorylates S24, the structural basis of MLF2–USP7–p53 interactions, whether MLF2's NE-lumen localization and its p53-regulatory function are mechanistically connected, and its direct role (if any) in NPC biogenesis.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No structural data for MLF2 or its complexes\",\n        \"Functional relationship between nuclear envelope and p53 regulatory roles unexplored\",\n        \"Endogenous interactome beyond USP7, p53, and NPC components not systematically mapped\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005635\", \"supporting_discovery_ids\": [1, 5]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"USP7\",\n      \"TP53\",\n      \"POM121\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"MLF2 is a ubiquitously expressed protein that functions at the intersection of nuclear envelope biology, chromatin regulation, and p53-mediated tumor suppression. MLF2 localizes to the nuclear envelope lumen where it marks aberrant nuclear pore complex (NPC) intermediates in Torsin ATPase-deficient cells, with bleb formation dependent on the transmembrane nucleoporin POM121 and occurring immediately after post-mitotic nuclear envelope reformation [PMID:32342107]. MLF2 suppresses p53 stability by binding both p53 and the deubiquitinase USP7, thereby antagonizing USP7-mediated p53 deubiquitination and promoting p53 degradation, a mechanism that contributes to its oncogenic role in colorectal cancer [PMID:37438558]. MLF2 undergoes CRM1-dependent nucleocytoplasmic shuttling [PMID:26673895], binds mRNA [PMID:22658674], and requires phosphorylation at serine 24 for its oncogenic activity in chronic myeloid leukemia [PMID:31831854].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Identification of MLF2 as a novel gene with ubiquitous expression and chromosomal mapping to 12p13 established it as a paralog of MLF1, though no leukemia-associated rearrangements were found at the MLF2 locus.\",\n      \"evidence\": \"cDNA cloning, Northern blotting, FISH mapping, and Southern blotting of leukemia cell lines\",\n      \"pmids\": [\"8661158\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No functional role assigned\", \"Protein localization undetermined\", \"Relationship to leukemogenesis unclear despite chromosomal location\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Discovery that MLF2 directly contacts mRNA via UV crosslinking established an unexpected RNA-binding capacity for a protein with no canonical RNA-binding domain.\",\n      \"evidence\": \"UV crosslinking followed by oligo(dT) capture and mass spectrometry in HeLa cells\",\n      \"pmids\": [\"22658674\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific RNA targets unknown\", \"Functional consequence of mRNA binding not determined\", \"RNA-binding domain or motif not mapped\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identification of MLF2 as a CRM1-dependent nuclear export substrate revealed that the protein undergoes active nucleocytoplasmic shuttling, providing a mechanistic basis for its presence in both nuclear and cytoplasmic compartments.\",\n      \"evidence\": \"Quantitative mass spectrometry with CRM1 inhibition (leptomycin B) in human cells\",\n      \"pmids\": [\"26673895\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Nuclear export signal not mapped within MLF2\", \"Functional significance of shuttling not established\", \"Whether shuttling regulates MLF2 activity unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrating that phosphorylation at serine 24 is required for MLF2's oncogenic activity in CML resolved how a post-translational modification controls MLF2 function in leukemogenesis.\",\n      \"evidence\": \"Phos-tag SDS-PAGE, S24A mutagenesis abolishing colony formation in vitro and leukemogenesis in a mouse survival model\",\n      \"pmids\": [\"31831854\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Kinase responsible for S24 phosphorylation not identified\", \"Downstream effectors of phospho-MLF2 in CML unknown\", \"Whether S24 phosphorylation affects p53-related or NPC-related functions not tested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Establishing MLF2 as a luminal component of nuclear envelope blebs in Torsin-deficient cells, dependent on POM121 and representing stalled NPC intermediates, provided the first mechanistic link between MLF2, nuclear pore biogenesis, and the nuclear envelope.\",\n      \"evidence\": \"Proteomics, live-cell imaging with MLF2 reporter, genetic epistasis showing POM121 dependence and Nup358 underrepresentation\",\n      \"pmids\": [\"32342107\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How MLF2 is recruited to the NE lumen is unknown\", \"Whether MLF2 is functionally required for NPC biogenesis or is a passive marker not resolved\", \"Relationship between NE bleb phenotype and Torsin-linked dystonia pathology not established\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Discovery that MLF2 interacts with both p53 and USP7 to antagonize USP7-mediated p53 deubiquitination defined a molecular mechanism for MLF2's oncogenic activity, explaining how MLF2 promotes p53 destabilization in colorectal cancer.\",\n      \"evidence\": \"Reciprocal co-immunoprecipitation of MLF2/p53/USP7, ubiquitination assays, knockdown and overexpression with p53 stability readouts in colorectal cancer cells\",\n      \"pmids\": [\"37438558\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether MLF2-USP7 interaction also affects MDM2 stability not fully dissected\", \"Structural basis of the ternary complex unknown\", \"Whether the p53-suppression mechanism operates in CML or other MLF2-linked cancers not tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include whether MLF2 plays an active functional role in NPC biogenesis versus serving as a passive marker, the identity of the kinase phosphorylating S24, the specific mRNA targets bound by MLF2, and whether its disparate roles in chromatin remodeling, p53 regulation, and nuclear envelope biology are mechanistically linked or context-dependent.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model of MLF2 exists\", \"Integration of RNA-binding, p53 regulation, NPC biology, and SWI/SNF functions into a unified model is lacking\", \"In vivo genetic models (knockout mouse) have not been reported\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [8, 9]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005635\", \"supporting_discovery_ids\": [7, 10]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [5, 7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [7, 10]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [4, 6, 8]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"USP7\",\n      \"TP53\",\n      \"POM121\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}